Measurement of the urinary excretion of lutropin (LH) and follitropin (FSH) and their common free alpha subunit (FAS) assists in monitoring the maturation of the hypothalamicpituitary-gonadal axis and in understanding the physiology of the pituitary glycoprotein hormones. Here we describe sensitive, specific polyclonal radioimmunoassays for LH and FSH and a monoclonal radioimmunoassay for FAS for use with urine-assays unperturbed by alterations in urinary pH or osmolarity within the broad physiological range encountered in urine. Concordance between LH, FSH, and FAS concentrations in extracted and unextracted urine samples was high. Linearity and parallelism with the standard curves was observed with addition of 25 to 200 L of unextracted urine. No effect on glycoprotein concentration was seen after as many as 10 freeze-thaw cycles. The need for extraction was further obviated by the high sensitivity of each assay, reflected by minimum detectable doses well below the concentrations encountered in patients' samples. Thus we have measured gonadotropins in unextracted urine as precisely as in extracted urine. We also have demonstrated an equally versatile assay for urinary alpha subunit, using a monocional antibody of high specificity for this monomer in its free, uncombined form. These radioimmunoassays complement assays of gonadotropins and free alpha subunit in serum and will allow longitudinal investigations otherwise limited by the constraints ofthe patient's blood volume.
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Measurement of the urinary excretion of lutropin (LH) and follitropin (FSH) and their common free alpha subunit (FAS) assists in monitoring the maturation of the hypothalamicpituitary-gonadal axis and in understanding the physiology of the pituitary glycoprotein hormones. Here we describe sensitive, specific polyclonal radioimmunoassays for LH and FSH and a monoclonal radioimmunoassay for FAS for use with urine-assays unperturbed by alterations in urinary pH or osmolarity within the broad physiological range encountered in urine. Concordance between LH, FSH, and FAS concentrations in extracted and unextracted urine samples was high. Linearity and parallelism with the standard curves was observed with addition of 25 to 200 L of unextracted urine. No effect on glycoprotein concentration was seen after as many as 10 freeze-thaw cycles. The need for extraction was further obviated by the high sensitivity of each assay, reflected by minimum detectable doses well below the concentrations encountered in patients' samples. Thus we have measured gonadotropins in unextracted urine as precisely as in extracted urine. We also have demonstrated an equally versatile assay for urinary alpha subunit, using a monocional antibody of high specificity for this monomer in its free, uncombined form. These radioimmunoassays complement assays of gonadotropins and free alpha subunit in serum and will allow longitudinal investigations otherwise limited by the constraints ofthe patient's blood volume.
The episodic nature of gonadotropin secretion requires that blood be sampled at frequent intervals, if the concentrations of the intact hormones and their subunits in serum are to be accurately assessed (1).Such sampling is invasive and cumbersome, and the small blood volumes of children make repeated frequent sampling unfeasible. Although measurements in urine cannot give detailed information regarding the pulsatile secretion of gonadotropins and their subunits by the pituitary, they are useful as a reflection of the integrated secretion of these glycoproteins over time (2) and, by inference, as a measure of hypothalamic gonadoliberin (GnRH) secretory activity.3 Urine specimens are easy to obtain, even in young children, and urinary gonadotropin excretion has been shown to correlate well with stage of puberty as well as with many other physiological and pathological states (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) cause concentrations of hormones in serum are also affected by their metabolic and renal rates of clearance, measurements of the intact hormones as well as of their subunits in urine are important for a full understanding of glycoprotein physiology.
In the past, most investigators have extracted urine to achieve adequate specificity and sensitivity in their gonadotropin measurements.
Such extractions are time-consuming and conceivably could result in the loss of important moieties of the glycoproteins. We have previously reported radioimmunoassays for lutropin (LH) and follitropin (FSH) in serum, involving polyclonal antisera highly specific for each of these hormones (16) . More recently, we also described a highly sensitive monoclonal radioimmunoassay specific for the free alpha subunit (FAS) of the glycoprotein hormones (17) . We now describe the adaptation and validation of these assays for use with both extracted urine and fresh, unextracted urine. Raiti and Blizzard (18) : We adjusted 5 mL of urine to pH 4.5 with concentrated glacial acetic acid, mixed this with two volumes of acetone, and incubated for 30 mm. We then centrifuged the incubation mixture at 1400 x g for 10 miii, decanted it, and air-dried the pellet for 1 h. After resuspending the pellet in assay buffer [10 mmol/L phosphatebuffered isotonic saline (PBS) containing 5 mL of NRS per liter, pH 7.01, we recentrifuged as above and stored the supernatant fluid at -20 #{176}C until analysis. To assess the effect of urinary pH on extraction efficiency, we divided another sample into aliquots and, before the extraction, adjusted the pH of the individual aliquots to various values from 3 to 10, using concentrated HC1 or NaOH.
Materials and Methods

Reagents
To assess analytical recovery of unlabeled hormone, we diluted hLH, hFSH, and hCGa in unextracted urine from a hypopituitary subject to concentrations equivalent to 80%, 50%, and 20% binding (B/B0) on the corresponding stan-dard curves. An aliquot of each sample was then extracted as above and aliquots of the extracted and unextracted samples were assayed for LH, FSH, and FAS as described below. We calculated recovery by dividing the concentrations of the extracted urine by those of the unextracted urine and converting to percentages.
Urinary gonadotropin radioimmunoassays.
Urinary LH and FSH were determined according to the method of Filicori et al. (16) , with some modifications. Urinary LH and FSH standards were serially diluted in assay buffer to give concentrations ranging from 0.8 to 50 mt. units/L (standardized according to the Second International Reference Preparation, human menopausal gonadotropins). To assay samples,we added 100 j.L of urine (range 50-200 tL) to 200 L of assay buffer containing 3.1 g of EDTA per liter. We then added 100 cLLof polyclonal antiserum to each tube except for those used to calculate nonspecific binding; the latter instead received 100 .tL ofassaybuffer containing 42 g of BSA per liter (PBS-NRS-BSA). The LH antiserum was raised in-house and was diluted to an initial titer of 1:196 000 in PBS-NRS-BSA (final titer 1:980 000). The FSH antiserum, obtained from Serono Laboratories, was diluted to give an initial titer of 1:45 000 in PBS-NRS-BSA (final titer 1:225 000). We then vortex-mixed the contents of the tubes and incubated them at room temperature for 20-24 h before adding labeled antigen: human choriogonadotropin (hCG) from Dr. R. E. Canfleld, College of Physicians & Surgeons, Columbia University, New York, NY, and purified FSH (KABI Vitrum, Stockholm, Sweden) labeled with 1251to a specific activity of approximately 210 CiIg and diluted in assay buffer. After adding 100 p.L (22 500 counts/mu) of labeled gonadotropun, we vortexmixed the tube contents, then incubated them at room temperature for an additional 20-24 h. Bound hormone was then precipitated by incubation for 1 h at 4#{176}C with 0.4 mL of an equivolume mixture of goat anti-rabbit antibody (20-fold diluted in 10 mmol/L PBS, pH 7.0) and polyethylene glycol (160 g/L). The reaction mixture was then centrifuged at 4200 x g at 4 #{176}C for 30 miii, the supernate was aspirated, and the radioactivity of the pellet was counted in a gamma counter for 1 mm.
Cross-reactivity of the LH antibody forFAS, FSH, and hCG was 2.1%, 3.9%, and >90%, respectively, and that of the FSH antibody for FAS, LH, and hCG was <0.03% for all three.
Urinary FAS radioimmunoassays. FAS determinations were performed accordingtothe method ofWhitcomb et al. (17) , with urine substituted for serum. In addition, to assess whether the monoclonal antibody was interacting with the major urinary FAS moieties in urine, we compared results with those obtained by using a polyclonal FAS antiserum
The cross-reactivities of the FAS monoclonal (17) and polyclonal antibodies for LH were 0.67% and 17.2%, for FSH 2.32% and 14.5%, and for hCG 0.09% and 15.3%, respectively.
Validation of the use of unextracted urine. To validate the use of unextracted urine in our gonadotropin and monoclonal FAS radioimmunoassays, we performed the following variations on the experiments of Bourguignon et al. (13): (a) To assess the effect of the pH of unextracted urine on each assay, we divided a sample of fresh, unextracted urine into aliquots and adjusted the pH of individual aliquots to values ranging from 4 to 10, using concentrated HC1 or NaOH. We then assayed the aliquots for LH, FSH, and FAS, and compared the results with those of the original sample. (b) Extracted and unextracted patients' samples were run in the same assays and the results analyzed by regression analysis. (c)A nonspecific effect of urine on each radioimmunoassay was assessed by comparing standard curves prepared in unextracted and extracted urine from a hypopituitary patient with the standard curve in buffer. We assessed linearity by assaying from 25 to 200 tL of urine from patients' specimens with high, middle, and low concentrations of each glycoprotein. (d) To assess the effect on assay performance of the high osmolar environments likely to be encountered in concentrated urines, a single sample was run in buffer with increasing concentrations of NaC1 (0 to 3.0 mol!L). In addition, unextracted urine was subjected to up to 10 freeze-thaw cycles during 10 days, in an experiment to assess the short-term impact of storage and reuse on the stability of gonadotropins and FAS in urine. Finally, we calculated intra-and interassay coefficients of variation and minimum detectable doses for each glycoprotemn.
Patients' specimens. To obtain normal mean values and ranges of urinary gonadotropins and FAS, we collected random (untimed) morning urine samples from the following groups: (a)clinically euthyroid prepubertal children of both sexes (ages four to eight years, n = 11), (b) men (ages 21 to 38, n = 14), and (c)women (ages 26 to 42, n = 17) who were in the follicular phase (days 2-9) of the menstrual cycle. After collection, urines were stored at 4 #{176}C in polypropylene containers for no longer than four weeks until analysis (20) .
Data analysis. Concentrations of gonadotropins and FAS and minimum detectable doses were calculated with fourparameter best-fit computer programs (21) . Urinary LH and FSH were expressed in mt. units/L and FAS in tg/L.
Concentrations were expressed in terms of grams of creatmine in the patients' samples.
Results
Extraction.
We observed no effect on the measured urinary concentrations of LH and FSH when extractions were carried out on aliquots of a urine sample adjusted to pH values ranging from 4 to 8. Above pH 8, the concentration of LH gradually declined, whereas at pH 3 FSH was undetectable. In contrast, FAS values remained unchanged regardless of the pH at which extraction was carried out. Thus, there was no pH effect on gonadotropmn or FAS extraction within the physiological range of urine (pH 4.8 to 7.5).
Analytical recoveries. Recoveries of LH at 80%, 50%, and 20% binding were 73%, 70%, and 95%, respectively; those of FSH were 88%, 85%, and 100%, respectively; and those of FAS 65%, 82%, and 81%, respectively.
Use of unextracted urine. From pH 4 to 8, we found no effect of pH of unextracted urine on the measured concentration of LII, FSH, or FAS. At pH 8 and above, FAS values were slightly higher.
Aliquots of 43 patients' urine samples (32 for FAS) were extracted and run with unextracted samples in the same assays for LH, FSH, and FAS. As shown in Figure 1 , correlation between extracted and unextracted samples for both gonadotropins and FAS was high (r = 0.99, P 0.0001 for each), and the slope of the regression line approached unity.
Standard curves for LH and FSH in buffer and in extracted and unextracted hypopituitary urine were statisti- (Figure 2 ). We did not observe parallelism between standard curves for FAS in buffer or in extracted and unextracted urine when we used the commercially available hCGa standard, possibly owing to dilution of the standard in a balanced serum. When lyophilized hLHa (NIH) was used as standard, however, parallelism was obtained ( Figure 2 ). The curves in buffer obtamned with the two alpha subunit preparations were parallel to one another, with 1 pg of the commercial alpha standard equal to 3.6 pg of the NIH standard. Addition of from 25 to 200 jL of urine at high, middle, and low concentrations of LH, FSH, and FAS showed linearity and parallelism with the respective standard curve (Figure 2) .
We found no effect of osmolarity on the polyclonal assays for urinary LH and FAS with increasing concentrations of NaC1 up to 3.0 mol/L. FSH, on the other hand, showed a gradual upward trend with increasing osmolarity. Within the physiological range (up to 1.5 moIJL NaC1), however, these differences were not substantial.
The 10 freeze-thaw cycles had no effect on measured LH, FSH, and FAS concentrations.
The intra-assay CVs at 20%, 50%, and 80% binding ranged from 4.7% to 6.6% for LII (ii = 10), 2.4% to 7.3% for FSH (n = 6), and 2.1% to 10.7% for FAS (n = 4). Interassay CVs ranged from 2.9% to 5.7% for LII (n = 10), 2.8% to 13.4% for FSH (n = 6), and from 4.0% to 12.0% for FAS (n = 4). The minimum detectable dose of each assay, statistically defined as the B0 point plus two times the standard deviation of a least-squares analysis of the curve as a whole (21), was 1.0 mt.unitlL, 1.0 mt.unit/L, and 0.07 jtg/L for LH, FSH, and FAS, respectively.
To ensure that our monoclonal antibody for FAS was not excluding any major species of the subunit in urine, we compared its ability to recognize FAS in 32 urine samples with that of the polyclonal FAS antibody. Regression analysis described a line with a slope of 1.15 and an intercept of 0.02 zg/L (r = 0.96, P 0.0001), suggesting that we were indeed identifying the major species of FAS in urine with the monoclonal antibody. Table 1 summarizes mean values and ranges of urinary gonadotropins and FAS in fresh, unextracted urine indexed against creatinine in the 14 normal men <40 years of age, the 17 normal women in the early follicular phase of the menstrual cycle, and the 11 normal prepubertal children (Tanner stage 1) ages four to eight years.
DiscussIon
Evidently, urinary gonadotropins and FAS can be accurately measured in both extracted and fresh, unextracted urine. Although previous studies indicated that extraction of urinary gonadotropins was essential because of the nonlinearity of results for unextracted samples on serial dilution (18), our findings are consistent with more recent investigations showing that extraction may not be necessaryexceptas a means ofconcentrating urinaryhormones (13).The most likelyexplanationforthis discrepancy is that the more beta subunit-specific antisera or conformationally specific antisera for the hormones in question show less cross-reactivity in assays and thus greater specificity with progressive dilution of antigen. Because the minimum detectable dose of each assay in the present report was well below the glycoprotein concentrations encountered even in prepubertal children, and because we were able to demonstrate linearity with sample volumes from 25 to 200 iL with parallelism to the standard curve, there appears to be little reason under most circumstances to concentrate urine for purposes of analysis. The ability of our assays to measure gonadotropins and FAS independent of the osmolar environment or pH of urine samples further establishes the use of fresh, unextracted urine in clinical studies despite broad physiological variability.
In addition, the absence of a significant effect of repetitive freezing and thawing on measured hormone concentrations suggests a high stability of gonadotropin and FAS in unextracted urine, at least in the short term.
We did note a discrepancy between analytical recoveries of the gonadotropins and FAS on the one hand and the comparison of extracted and unextracted patient samples on the other. In the gonadotropin assays, this difference diminished with increasing dose, and recoveries approached 100% at 20% binding. This suggests a small but fixed, unrecoverablelossofLH and FSH immunoreactivity 1-1 0.1) independent of hormone concentration, perhaps owing to the extraction processitself. We observed a similarbut even greaterdiscrepancywith FAS, for which maximal analytical recoveries were only 80% despitenear-unity in the regression analysis of extracted and unextracted samples from patients. The most likely explanation for this observation is that the dissociation of intact, dimeric hormones in the preparation of reference standards results in the generation of non-extractable, alpha-subunit-like material that is not normally present in urine. These findings further support the use of unextracted urine whenever possible.
There are broad clinical applications for urinary gonadotropin and FAS radioimmunoassays.
Previous studies have demonstrated that urinary gonadotropin values correlate closely with the clinical stage of puberty (3, 4, 7, 8, 10, 13) and may be even more sensitive than measurements in serum for detecting the early pubertal rise in nocturnal gonadotropmn secretion (8) . Urinary gonadotropin determinations have been useful in assessing the dogree of pituitary suppression during desensitizationwith long-acting GnRH analogs (15),the response to exogenous GnRH (9, 11, 14) , and the timing of the pre-ovulatory LH surge (5,22). Urinary FAS may also prove to be of use in physiological settings, where it may be a more sensitive marker of GnRH secretion than intact gonadotropmns, and in pathological settings, where secretion of FAS is increased, such as with certain pituitary tumors (19,23-25), the carcinoid syndrome (26),and trophoblastic disease (27).
The urinary assay systems described herein, in combination with serum studies, will be useful in exploring the physiology and metabolism of the gonadotropins and their subunits. Our observation that prepubertal children excrete larger amounts of FAS (when indexed against creatmine) than do adults suggests the existence of a constitutively synthesized pool of FAS, which may be diminished with the advent of puberty and the availability of combinable LHI3 and FSHI3 subunits. Further studies are needed to confirm these results and to monitor changes in gonadotropin and FAS secretion and excretion during neuroendocrine maturation. The advent of these highly versatile, sensitive, and specific assay systems, and their applicability to both serum and urine, make such longitudinal studieshighly feasible. Angiotensin-converting enzyme (ACE) was measured in serum of 187 healthy children between the ages six months and 18 years. Results were pooled for five-year age intervals and compared with the reference values for adults that we previously determined [din Chem 1986;32:884-6). Results for each age group were also studied as a function of sex. Children had higher ACE activities in serum than did adults (P <0.001), but these activities were age-related only from age four to 18 years. Adolescents showed sex-related differences, with higher serum ACE activities in boys than in girls (P <0.05). Both sex-and age-related differences may be related to a steroid hormonal regulation of ACE biosynthesis. We also verified that children with sarcoidosis (n = 20) had significantly increased serum ACE activity. Such physiological variations in serum ACE activity must be taken into account for diagnosing sarcoidosis in children, for following the course of the disease, and for evaluating the accuracy of therapy. determined for several enzymatic assays(2,3),but little is known about the reference values for serum of children, even though sarcoidosis has been widely described in children and young adults (4, 5) . The substrate N-[3-
permits kinetic assays of ACE activity. We previously reported an automated determination of serum ACE activity based on use of this substrate with a discrete analyzer and demonstrated the reliability, rapidity, and simplicity of the assay that makes it suitable for routine use and for clinical investigations of ACE (6) .
In the present study, using the same enzymic assay, we measured ACE in serum of 187 healthy children, ages six months to 18 years, to determine whether there were ageand sex-related differences in the normal reference intervaL
Subjects and Methods
Subjects. We obtained serum samples from 187 apparently healthy children (95 girls, 92 boys) during a consultation for routine health control in the Center of Preventive Medicine of Vandoeuvre-les-Nancy (ages six months to four years) and the Pediatry Medical Center of Paris 12 (ages four to 18 years). We arbitrarily grouped the 187 subjects into five-year age intervals. We also studied the results for each group according to sex.
We also collected sera from 20 children with active sarcoidosis confirmed by clinical findings plus a positive biopsy (Department of Pediatric Pneumology, Trousseau Hospital, Paris).
Determination oIACE in serum. ACE activity was determined according to the automated method previously doscribed, with FAPGG as the substrate (6) . One unit (1 U) of ACE activity is the amount of enzyme that hydrolyzes 1 lLmol of FAPGG per minute at 37#{176}C.
Data analysis. For statistical comparison we used Student's t-test for non-paired data. Table 1 summarizes the ACE activity in serum of
Results
